Cargando…
Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes
SIMPLE SUMMARY: Ovarian cancer is one of the deadliest female cancers with very poor survival, primarily due to late diagnosis, recurrence and chemoresistance. Although the over-expression of plasma gelsolin (pGSN) protects ovarian cancer cells from chemotherapy-induced death, its immunological role...
Autores principales: | Asare-Werehene, Meshach, Tsuyoshi, Hideaki, Zhang, Huilin, Salehi, Reza, Chang, Chia-Yu, Carmona, Euridice, Librach, Clifford L., Mes-Masson, Anne-Marie, Chang, Chia-Ching, Burger, Dylan, Yoshida, Yoshio, Tsang, Benjamin K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870487/ https://www.ncbi.nlm.nih.gov/pubmed/35205790 http://dx.doi.org/10.3390/cancers14041039 |
Ejemplares similares
-
Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance
por: Onuma, Toshimichi, et al.
Publicado: (2022) -
Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin
por: Gerber, Emma, et al.
Publicado: (2023) -
Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer
por: Asare-Werehene, Meshach, et al.
Publicado: (2019) -
The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance
por: Asare-Werehene, Meshach, et al.
Publicado: (2019) -
Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand
por: Chiu, Chen-Tzu, et al.
Publicado: (2020)